235 related articles for article (PubMed ID: 15171958)
21. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
Ahrens I; Peter K; Bode C
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
[TBL] [Abstract][Full Text] [Related]
22. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Vorchheimer DA; Badimon JJ; Fuster V
JAMA; 1999 Apr; 281(15):1407-14. PubMed ID: 10217057
[TBL] [Abstract][Full Text] [Related]
23. Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment.
Brown DL
Heart; 2003 May; 89(5):535-7. PubMed ID: 12695459
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Konstantopoulos K; Mousa SA
Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
[TBL] [Abstract][Full Text] [Related]
25. Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseases.
Chong PH
Am J Health Syst Pharm; 1998 Nov; 55(22):2363-86. PubMed ID: 9825033
[TBL] [Abstract][Full Text] [Related]
26. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.
Koster A; Meyer O; Fischer T; Kukucka M; Krabatsch T; Bauer M; Kuppe H; Hetzer R
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1254-5. PubMed ID: 11726910
[No Abstract] [Full Text] [Related]
27. Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.
Said SM; Hahn J; Schleyer E; Müller M; Fiedler GM; Buerke M; Prondzinsky R
Clin Res Cardiol; 2007 Feb; 96(2):61-9. PubMed ID: 17146606
[TBL] [Abstract][Full Text] [Related]
28. Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients.
Mak KH; Effron MB; Moliterno DJ
Drugs Aging; 2000 Mar; 16(3):179-87. PubMed ID: 10803858
[TBL] [Abstract][Full Text] [Related]
29. Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development.
Verstraete M
Circulation; 2000 Feb; 101(6):E76-80. PubMed ID: 10673265
[TBL] [Abstract][Full Text] [Related]
30. Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
MacCallum EM; Hanlon SJ; Byrne KH
Dimens Crit Care Nurs; 2000; 19(3):14-9. PubMed ID: 11998001
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors.
Kleiman NS
Am Heart J; 1999 Oct; 138(4 Pt 2):263-75. PubMed ID: 10502232
[TBL] [Abstract][Full Text] [Related]
32. Off-target effects of glycoprotein IIb/IIIa receptor inhibitors.
Ostrowska M; Adamski P; Koziński M; Navarese EP; Fabiszak T; Grześk G; Paciorek P; Kubica J
Cardiol J; 2014; 21(5):458-64. PubMed ID: 24526503
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon.
Dyke C; Bhatia D
J Cardiovasc Surg (Torino); 1999 Aug; 40(4):505-16. PubMed ID: 10532207
[TBL] [Abstract][Full Text] [Related]
34. [Platelet aggregation inhibitors in diabetes mellitus].
Abrahamian H
Acta Med Austriaca; 1999; 26(5):137-41. PubMed ID: 11512189
[TBL] [Abstract][Full Text] [Related]
35. Platelet GPIIb-IIIa blockers.
Topol EJ; Byzova TV; Plow EF
Lancet; 1999 Jan; 353(9148):227-31. PubMed ID: 9923894
[TBL] [Abstract][Full Text] [Related]
36. [GP IIb/IIIa receptor antagonists--molecular and clinical aspects].
Francuz T
Postepy Hig Med Dosw; 2001; 55(3):419-32. PubMed ID: 11505641
[TBL] [Abstract][Full Text] [Related]
37. Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.
Meier-Ewert HK; Nesto RW
Rev Cardiovasc Med; 2002; 3 Suppl 1():S20-7. PubMed ID: 12439433
[TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of glycoprotein IIb/IIIa antagonists in acute coronary syndrome.
Latour-Pérez J
Ann Pharmacother; 2001 Apr; 35(4):472-9. PubMed ID: 11302412
[TBL] [Abstract][Full Text] [Related]
39. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
Tcheng JE
Am Heart J; 2000 Feb; 139(2 Pt 2):S38-45. PubMed ID: 10650315
[TBL] [Abstract][Full Text] [Related]
40. Bleeding risk of platelet glycoprotein IIb/IIIa receptor antagonists in broad-based practice (results from the Society for Cardiac Angiography and Interventions Registry).
Horwitz PA; Berlin JA; Sauer WH; Laskey WK; Krone RJ; Kimmel SE;
Am J Cardiol; 2003 Apr; 91(7):803-6. PubMed ID: 12667564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
